Skip to main content
. 2021 Mar 6;8(2):161–169. doi: 10.1016/j.ajur.2021.03.001

Figure 3.

Figure 3

Relapse rates according to different treatment strategies for NSGCT stage I [39,40]. RPLND, retroperitoneal lymph node dissection; NSGCT, non-seminomatous germ cell tumors; BEP, bleomycin, etoposide, and cisplatin.